EUVIMEDEUVIMED entdecken
Crossref

A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer

Meng Meng, Jiayan Wu, Yuanji Feng, Lin Lin, Jie Chen, Xuan Pang, Yanhui Li, Kai Hao, Huayu Tian iD, Xuesi Chen

Advanced Materials · 2024

DOI: 10.1002/adma.202314309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Meng Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Tumor Microenvironment, B7-H1 Antigen. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, the talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple negative breast cancer (TNBCs), known as an immunologically cold tumor, is difficult to completely eliminate with existing monotherapies, let alone metastasis and recurrence. It is urgent to design a rational combination of multiple therapies to programmatically reconstitute tumor microenvironment (TME) and reverse the immune “cold” into “hot” inflammatory tumors to improve the therapeutic effect. Hence, in this work, a multifunctional nanosystem (FeSH NPs) that integrates metal‐polyphenol coordination complex as a photothermal agent and polyphenol, salvianolic acid B (SAB) as immunomodulator is designed and fabricated for synergistic photothermal‐immunotherapy of TNBCs combined with anti‐PD‐L1 antibody. Guided by photothermal/photoacoustic dual‐mode imaging, photothermal therapy (PTT) caused by FeSH NPs induces immunogenic cell death (ICD) under 808 nm laser irradiation. Subsequently, the loaded SAB is released with the addition of deferoxamine mesylate (DFO) to remodel TME, specifically TGF‐β inhibition and PD‐L1 upregulation, and eliminate the primary tumors. The combination of PTT and TME reprogramming by FeSH NPs further synergizes with anti‐PD‐L1 antibody to eradicate recurrence and inhibit metastasis of TNBCs concurrently. Given the biosafety of FeSH NPs throughout the lifecycle, this work provides a protocol with high clinical translational promise for comprehensive programmed therapeutics of immunologically cold tumors TNBCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsImmunotherapyTumor MicroenvironmentB7-H1 AntigenAnimalsMiceHumansCell Line, TumorFemalePhotothermal TherapyPolyphenolsMultifunctional NanoparticlesTransforming Growth Factor betaCoordination Complexes

Stichwörter der Autor:innen

immune checkpoint blockadeprogrammable photothermal‐immunotherapytransforming growth factor βtriple negative breast cancertumor microenvironment reprogramming

Substanzen

B7-H1 AntigenPolyphenolsTransforming Growth Factor betaCoordination Complexes

Autor:innen und Institutionen

  • Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
  • State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen, 361005, China.
  • School of Materials Science and Engineering, Xiamen University of Technology, Xiamen, 361024, China.
  • Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province (IKKEM), Xiamen, 361005, China.

ORCID-Profile: Huayu Tian

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • the talent cultivation project Funds for the Innovation Laboratory for Sciences and Technologies of Energy Materials of Fujian Province
  • the Research Foundation for Advanced Talents of Xiamen University of Technology

Zitieren

APA

Meng, M., Wu, J., Feng, Y., Lin, L., Chen, J., Pang, X., Li, Y., Hao, K., Tian, H., & Chen, X. (2024). A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. https://doi.org/10.1002/adma.202314309

Vancouver

Meng M, Wu J, Feng Y, Lin L, Chen J, Pang X, et al. A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. 2024. doi:10.1002/adma.202314309

BibTeX
@article{Meng2024,
  author = {Meng, Meng and Wu, Jiayan and Feng, Yuanji and Lin, Lin and Chen, Jie and Pang, Xuan and Li, Yanhui and Hao, Kai and Tian, Huayu and Chen, Xuesi},
  title = {A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202314309}
}
Kostenlos starten →